Navigation Links
Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board
Date:2/27/2008

ties Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from our Company's expectations and projections. The most significant of such risks and uncertainties include, but are not limited to, our ability, and the ability of King Pharmaceuticals Research and Development, Inc. and other pharmaceutical companies, if any, with whom we may license our Aversion(R) Technology, to obtain necessary regulatory approvals and commercialize products utilizing the Aversion(R) Technology, the ability to avoid infringement of patents, trademarks and other proprietary rights or trade secrets of third parties, and the ability to fulfill the FDA's requirements for approving our product candidates for commercial manufacturing and distribution in the United States, including, without limitation, the adequacy of the results of the clinical studies completed to date and the results of other clinical studies, to support FDA approval of our product candidates, the adequacy of the development program for our product candidates, changes in regulatory requirements, adverse safety findings relating to our product candidates, the risk that the FDA may not agree with our analysis of its clinical studies and may evaluate the results of these studies by different methods or conclude that the results of the studies are not statistically significant, clinically meaningful or that there were human errors in the conduct of the studies or otherwise, the risk that further studies of our product candidates are not positive, and the uncertainties inherent in scientific research, drug development, clinical trials, the regulatory approval process, and commercial supply. You are encouraged to review other important risk factors relating to our operations on our web site at http://www.acur
'/>"/>

SOURCE Acura Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion(R) (Abuse-Deterrent) Technology
2. Acura Pharmaceuticals, Inc. Announces Implementation of Reverse Stock Split and New Trading Symbol: ACPH
3. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
4. Acura Pharmaceuticals, Inc. Announces Approval to List Shares on NASDAQ and Effective Feb. 4, 2008 a New Trading Symbol: ACUR
5. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
9. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
10. ACG Announces Major Gift by Salix Pharmaceuticals, Inc.
11. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 ... on sales(at)researchmoz(dot)us , Researchmoz.us announces a new research ... with deep study of the report on the diabetes ... sugar. The global glucose monitoring market has a growth ... of diabetics in the world. Their numbers have prompted ...
(Date:11/26/2014)... November 26, 2014 For those with a ... LES MILLS BODYPUMP™ classes at the University of ... workout they've been looking for. The 45- 60 minute classes ... Health and Wellness Center fitness club memberships. , LES MILLS ... are fast-paced and are aimed at fast results , ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Sonoran ... ANP-BC, recently received the Distinguished Preceptorship Award from ... for her role in the advancement of nurse ... of an individual who had made a significant ... NPs. The American Association of Nurse Practitioners (AANP) ...
(Date:11/26/2014)... News) -- Vultures have developed highly specialized ways of ... dead animals, researchers report. The new research investigated ... and in the guts of 50 turkey vultures and ... faces of the vultures had more than 500 different ... the study found. The findings suggest that a ...
(Date:11/26/2014)... Nov. 25, 2014 (HealthDay News) -- Exposure to peanut ... peanut allergy in infants with the skin condition eczema, ... school-aged children in the United States are allergic to ... to food allergies, particularly peanut allergy, the researchers noted. ... months to 15 months. The researchers examined the amount ...
Breaking Medicine News(10 mins):Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:LES MILLS BODYPUMP™ classes come to the University of Colorado Anschutz Health and Wellness Center 2Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Infants With Eczema May Be More Prone to Peanut Allergy: Study 2
... ... Noni Fruit , ... (Vocus) May 19, 2010 -- Tahitian Noni International (TNI) has announced the creation ... company leaders have realized that noni is more than just a juice-and they are using ...
... ... Experience, View Their Photos, and Learn What Footwear To Pack for an African Safari , ... Seattle, Wash. (PRWEB) May 17, 2010 -- Good ... online shoe retailer before embarking on her honeymoon, vowing to pack only five pairs of shoes ...
... ... and young adults are ready for plastic surgery. , ... Voohees, NJ (Vocus) May 19, 2010 -- In light of recent media coverage of ... surgeon , Dr. Paul M. Parker, saw a great opportunity to address the right way to ...
... The neXante ... and xMM skin, respectively on Basal Cell Cancer, Squamous Cell Cancer, and Malignant Melanoma of ... only tracks and stores images of the skin, but also allows for recording the diagnosis, ... ...
... ... offers unique source of income for hard pressed primary care physicians. , ... Sacramento, CA (PRWEB) May 19, ... soon overwhelm private practice groups across the country with 31 million new patients. ...
... ... Angel Investors. , ... (PRWEB) May 19, 2010 -- SeniorHomes.com , an online directory and resource for ... it received a $1.1 million of Series A financing led by MentorTech Ventures of ...
Cached Medicine News:Health News:New Bioactive Beverages Available From Tahitian Noni International 2Health News:The Bachelor's Molly Malaney Blogs About Honeymoon at Onlineshoes.com 2Health News:The Bachelor's Molly Malaney Blogs About Honeymoon at Onlineshoes.com 3Health News:With the Right Approach, Plastic Surgery for Teens and Young Adults is Now a Positive Experience 2Health News:With the Right Approach, Plastic Surgery for Teens and Young Adults is Now a Positive Experience 3Health News:With the Right Approach, Plastic Surgery for Teens and Young Adults is Now a Positive Experience 4Health News:With the Right Approach, Plastic Surgery for Teens and Young Adults is Now a Positive Experience 5Health News:neXante Turns Apple's iPhone Into Skin Cancer Surveillance Support Tool And Health Record 2Health News:Physicians Preferred Wellness Group Receives Prestigious MD Preferred Service Award 2Health News:SeniorHomes.com Closes $1.1 Million Series A Round of Investment Financing 2
(Date:11/26/2014)... China, Nov. 26, 2014 China Nepstar Chain ... "Company"), a leading retail drugstore chain in China based ... its unaudited financial results for the third quarter ended September ... 30, 2014: , Same store sales increased by ... , Revenue increased by 8.1% to RMB738.3 million (US$120.3 million) ...
(Date:11/24/2014)...  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced today ... and update at the Piper Jaffray 26 th Annual ... Eastern Time (5:30 a.m. Pacific Time), at The New York ... A live audio webcast of the presentation will be ... www.arenapharm.com . A replay of the presentation will be ...
(Date:11/24/2014)... /PRNewswire/ - Milestone Pharmaceuticals, Inc. today announced data from a ... Melbourne, Australia of MSP-2017, a novel ... paroxysmal supraventricular tachycardia (PSVT).  The results demonstrated that ... at single doses up to and including 140 ... properties including rapid onset, and validating proof of ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 11Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 3Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 2Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 3
... Oct. 5, 2011 Reportlinker.com announces ... is available in its catalogue: ... Dermatological Drugs, 7th Edition ... This Kalorama Information report details the ...
... Calif., Oct. 5, 2011 In an independent study ... the University of Texas Health Science Center San Antonio ... to compromised blood flow during reconstructive microsurgery when compared ... study by Dr. Cornejo and colleagues is important as ...
Cached Medicine Technology:The Market for Prescription Dermatological Drugs, 7th Edition 2The Market for Prescription Dermatological Drugs, 7th Edition 3The Market for Prescription Dermatological Drugs, 7th Edition 4The Market for Prescription Dermatological Drugs, 7th Edition 5The Market for Prescription Dermatological Drugs, 7th Edition 6The Market for Prescription Dermatological Drugs, 7th Edition 7The Market for Prescription Dermatological Drugs, 7th Edition 8The Market for Prescription Dermatological Drugs, 7th Edition 9The Market for Prescription Dermatological Drugs, 7th Edition 10The Market for Prescription Dermatological Drugs, 7th Edition 11The Market for Prescription Dermatological Drugs, 7th Edition 12The Market for Prescription Dermatological Drugs, 7th Edition 13The Market for Prescription Dermatological Drugs, 7th Edition 14The Market for Prescription Dermatological Drugs, 7th Edition 15Spectros T-Stat Shown to Be Earliest Available Method for Detection of Surgical Skin Flap Compromise After Surgery 2
The Fathom Guidewire combines a nitinol hypotube distal segment with advanced microfabrication technology, creating a design that revolutionizes access of the most tortuous vasculature....
... for stent delivery. Uses perpendicular applied ... Allows user to adjust stent position ... tactile feel via fine adjustment and ... visualization at any angle. The Cordis ...
Vial with 100 Urine Reagent Test Strips, tests for glucose, protein, pH, blood, ketone, bilirubin, nitrite, urobilinogen, specific gravity. FOR LABORATORY USE BY QUALIFIED TECHNICIANS....
... the latest from Quality Mapping Solutions, ... designed specifically for implementing and managing ... superior design, functionality, security, and versatility ... managing a quality program., ,Based upon ...
Medicine Products: